Vaishali Pharma Financials

NSE: VAISHALI

₹8.32

₹-0.04 (-0.48%)

As on 04-Sep-2026 15:52IST

Market cap

₹112 Cr

Revenue (TTM)

₹108 Cr

P/E Ratio

26.5

P/B Ratio

1.4

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Operating Revenue	107.92	99.03	86.28	69.66	75.82	53.77
Total Income	111.49	102.23	88.31	71.89	77.61	55.58
Total Expenditure	103.69	98.45	84.61	60.28	68.94	51.13
EBITDA	4.23	0.57	1.67	9.38	6.89	2.65
Depreciation	0.60	0.49	0.51	0.50	0.46	0.43
EBIT	3.64	0.09	1.16	8.87	6.43	2.22
Interest	1.83	2.07	2.27	2.26	2.49	2.63
Other Income	3.57	3.21	2.03	2.23	1.79	1.81
Exceptional Items	--	--	--	--	--	--
Profit before Tax	5.38	1.23	0.93	8.85	5.73	1.40
Provision for Tax	1.14	0.41	0.21	2.24	1.70	0.36
Profit after Tax	4.24	0.82	0.72	6.60	4.02	1.05

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Shareholder's Funds	68.99	64.92	42.84	40.53	26.35	22.42
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.98	4.69	3.86	6.15	3.17	4.30
Current Liabilities	48.30	40.05	33.08	32.07	51.94	59.26
Total Liabilities	123.26	109.84	79.96	78.90	81.62	86.13

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Non-Current Assets	7.27	5.18	5.26	6.08	5.03	4.68
Current Assets	112.96	104.48	74.52	72.67	76.43	81.30
Total Assets	123.26	109.84	79.96	78.90	81.62	86.13
Total Debt*	--	11.66	12.61	13.66	20.76	17.57
Net Current Assets	64.67	64.43	41.44	40.60	24.49	22.03
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Cash From Operating Activities	--	-18.04	0.81	1.08	1.32	2.01
Cash Flow from Investing Activities	--	-0.19	1.20	0.28	-0.85	-0.11
Cash from Financing Activities	--	18.49	-1.42	-1.73	0.42	-1.81
Net Cash Inflow / Outflow	--	0.26	0.59	-0.37	0.89	0.09

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Adjusted EPS (₹)	0.34	0.06	0.07	0.63	0.38	0.10
Cash EPS (₹)	0.31	0.10	0.11	0.67	0.42	0.14
Adjusted Book Value (₹)	5.89	4.98	3.34	3.13	2.50	2.13
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-1.38	0.75	1.02	1.25	1.91
Free Cash Flow per Share (₹)	--	-1.90	-2.41	-0.52	-1.50	-1.36

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
ROCE (%)	--	4.99	5.82	21.92	18.87	10.33
ROE (%)	6.22	1.62	2.09	22.26	16.50	4.78
ROA (%)	3.64	0.86	0.91	8.24	4.81	1.38
EBIT Margin (%)	3.37	0.09	1.34	12.74	8.48	4.13
Net Margin (%)	3.80	0.80	0.81	9.19	5.18	1.88
Cash Profit Margin (%)	0.00	1.32	1.42	10.20	5.91	2.74

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Revenue Growth (%)	3.08	14.77	23.85	-8.12	41.00	-10.50
EBIT Growth (%)	360.27	-92.46	-86.93	38.03	189.46	379.88
Net Profit Growth (%)	968.51	13.70	-89.11	64.12	284.58	3,091.33
EPS Growth (%)	130.64	-6.56	-89.28	64.13	284.58	3,091.33
Book Value Growth (%)	--	81.26	8.62	25.11	17.56	4.85

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Price / Earnings	26.48	200.64	20.88	2.33	17.34	32.86
Price / Book Value	1.41	2.53	4.19	4.67	2.65	1.53
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	16.58	46.02	43.54	14.35	10.28	11.55
Close Price (₹)	7.21	12.58	14.01	14.59	6.62	3.26
High Price (₹)	13.59	24.91	20.36	19.38	7.23	7.71
Low Price (₹)	4.75	10.30	11.49	6.44	2.90	2.84
Market Cap (₹ Cr)	112.32	164.13	150.13	153.87	69.76	34.38

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debt to Equity	0.08	0.18	0.35	0.41	0.79	0.78
Short term debt to equity ratio	--	0.07	0.18	0.18	0.63	0.52
Current Ratio	2.34	2.61	2.25	2.27	1.47	1.37
Quick Ratio	2.27	2.49	2.24	2.17	1.46	1.36
Interest Coverage	3.95	1.59	1.41	4.92	3.30	1.53

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debtors to sales (%)	47.05	47.18	57.29	76.96	77.16	124.10
Asset Turnover	0.93	1.05	1.09	0.87	0.91	0.71
Receivable days	--	177.19	217.95	293.72	301.44	386.08
Inventory Days	--	9.56	7.25	9.64	2.93	4.98
Payable days	--	99.12	91.69	154.80	198.07	253.76
Cash Conversion Cycle	--	87.63	133.52	148.56	106.30	137.31

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)